We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSEX:NASDAQMiddlesex Water Company Analysis

Data as of 2026-06-13 - not real-time

$52.95

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Middlesex Water trades at $52.95, which is more than double the DCF‑derived fair value of $23.09 and carries a P/E of 22.1 versus the industry average of 20.5, suggesting the stock is currently overvalued. The company generates a solid 2.69% dividend yield with a payout ratio around 58%, but free cash flow is negative ($‑30.4 M) despite positive operating cash flow, and a high debt‑to‑equity ratio of 85% raises concerns about leverage. Revenue growth remains healthy at 10% YoY and margins are respectable (gross 53%, operating 29%), supporting the dividend and providing some cushion.
Technically, the price sits just above the 20‑day ($52.23) and 50‑day ($52.36) SMAs but below the 200‑day SMA ($53.01), aligning with a bearish trend designation. MACD shows a bullish crossover, RSI is neutral at 53, and the stock is trading near its support level of $50.24 with resistance at $54.97. Volatility is moderate‑high at 19.6% over 30 days, while a slightly negative beta (‑0.11) indicates defensive behavior, and liquidity appears adequate with stable volume.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Current price near support with limited upside
  • Overvaluation relative to DCF and peers
  • Stable dividend yield provides income cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Target price of $60 implies ~13% upside
  • Regulated revenue base supports cash flow stability
  • Attractive dividend yield for income‑focused investors

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term defensive beta and low sector risk
  • High leverage and negative free cash flow limit upside
  • Consistent dividend payments enhance total return

Key Metrics & Analysis

Financial Health

Revenue Growth10.00%
Profit Margin22.07%
P/E Ratio22.1
ROE9.22%
ROA2.84%
Debt/Equity85.19
P/B Ratio2.0
Op. Cash Flow$60.5M
Free Cash Flow$-30407376
Industry P/E20.5

Technical Analysis

TrendBearish
RSI53.2
Support$50.24
Resistance$54.97
MA 20$52.23
MA 50$52.36
MA 200$53.01
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$23.09
Target Price$60.00
Upside/Downside13.33%
GradeOvervalued
TypeValue
Dividend Yield2.69%

Risk Assessment

Beta-0.11
Volatility19.57%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.